English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52707031    線上人數 :  500
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"yen y h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-10 / 64 (共7頁)
1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-09-19T03:17:19Z Prevention and monitoring of hepatotoxicity among patients receiving antituberculosis medications FEI-YUAN HSIAO; Yen Y.-H.; Lee C.-N.; Huang W.-F.; Chen H.-Y.
臺大學術典藏 2022-09-15T01:09:01Z A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors Lee J.-H.; Chen T.W.-W.; Hsu C.-H.; Yen Y.-H.; Yang J.C.-H.; Cheng A.-L.; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Chia-Chi Lin
臺大學術典藏 2022-09-07T06:50:29Z Sex differences in conscious sedation during upper gastrointestinal panendoscopic examination Yen Y.-H.; Lin T.-F.; Lin C.-J.; YI-CHIA LEE; Lau H.-P.; Yeh H.-M.
臺大學術典藏 2022-04-21T06:50:39Z A polymorphism in interferon L3 Is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis c virus infection Chang K.-C.; Tseng P.-L.; Wu Y.-Y.; Hung H.-C.; Huang C.-M.; Lu S.-N.; Wang J.-H.; Lee C.-M.; Chen C.-H.; Tsai M.-C.; Yen Y.-H.; Lin M.-T.; Wu C.-K.; Huang C.-C.; Chen, Tony Hsiu Hsi; Hu T.-H.
臺大學術典藏 2022-04-15T06:39:21Z Intensive care unit-acquired weakness Siao S.-F.; Yen Y.-H.; Yu Y.-F.; Zong S.-L.; CHERYL CHIA-HUI CHEN
臺大學術典藏 2022-03-15T05:39:21Z A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors Lee J.-H.; WEI-WU CHEN; Hsu C.-H.; Yen Y.-H.; Yang J.C.-H.; Cheng A.-L.; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Lin C.-C.
臺大學術典藏 2022-03-09T03:12:42Z Serum and endometrial markers Yang W.-C.V.; HUEI-WEN CHEN; Au H.-K.; Chang C.-W.; Huang C.-T.; Yen Y.-H.; Tzeng C.-R.
臺大學術典藏 2022-02-23T02:12:21Z Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment Lin M.-T.; Chang K.-C.; Yen Y.-H.; Tsai M.-C.; CHIEN-HUNG CHEN; Wang J.-H.; Hsiao C.-C.; Chiu Y.-H.; Hu T.-H.
臺大學術典藏 2022-02-23T02:12:18Z Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (Front. Oncol., (2021), 11, (737767), 10.3389/fonc.2021.737767) Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.
臺大學術典藏 2022-02-23T02:12:18Z Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H.

顯示項目 1-10 / 64 (共7頁)
1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目